Neuland has focused on R&D as a prime driver in further strengthening the overall business and growth of the company. Our emphasis has been on developing processes which are cost effective, safe to handle and has an advantage in terms of product outputs. Keeping focus on this, our aim is to become a preferred source to global pharma companies in terms of custom research, New Chemical Entity (NCE) development & R&D services.

At Neuland, intellectual property has been the cutting edge advantage. Customers have perceived it as our core competence, expecting us to add value to their products.

Product development, Process Engineering and scale up of operations have remained the core strengths. Synthesizing impurities, identifying & profiling them add to Neuland’s ability to offer customer better quality products.